Literature DB >> 24531811

Altered reactivity and nitric oxide signaling in the isolated thoracic duct from an ovine model of congenital heart disease with increased pulmonary blood flow.

Sanjeev A Datar1, Peter E Oishi, Wenhui Gong, Stephen H Bennett, Christine E Sun, Michael Johengen, Jun Maki, Rebecca C Johnson, Gary W Raff, Jeffrey R Fineman.   

Abstract

We have previously shown decreased pulmonary lymph flow in our lamb model of chronically increased pulmonary blood flow, created by the in utero placement of an 8-mm aortopulmonary shunt. The purpose of this study was to test the hypothesis that abnormal lymphatic function in shunt lambs is due to impaired lymphatic endothelial nitric oxide (NO)-cGMP signaling resulting in increased lymphatic vascular constriction and/or impaired relaxation. Thoracic duct rings were isolated from 4-wk-old shunt (n = 7) and normal (n = 7) lambs to determine length-tension properties, vascular reactivity, and endothelial NO synthase protein. At baseline, shunt thoracic duct rings had 2.6-fold higher peak to peak tension and a 2-fold increase in the strength of contractions compared with normal rings (P < 0.05). In response to norepinephrine, shunt thoracic duct rings had a 2.4-fold increase in vascular tone compared with normal rings (P < 0.05) and impaired relaxation in response to the endothelium-dependent dilator acetylcholine (63% vs. 13%, P < 0.05). In vivo, inhaled NO (40 ppm) increased pulmonary lymph flow (normalized for resistance) ∼1.5-fold in both normal and shunt lambs (P < 0.05). Inhaled NO exposure increased bioavailable NO [nitrite/nitrate (NOx); ∼2.5-fold in normal lambs and ∼3.4-fold in shunt lambs] and cGMP (∼2.5-fold in both) in the pulmonary lymph effluent (P < 0.05). Chronic exposure to increased pulmonary blood flow is associated with pulmonary lymphatic endothelial injury that disrupts NO-cGMP signaling, leading to increased resting vasoconstriction, increased maximal strength of contraction, and impaired endothelium-dependent relaxation. Inhaled NO increases pulmonary lymph NOx and cGMP levels and pulmonary lymph flow in normal and shunt lambs. Therapies that augment NO-cGMP signaling within the lymphatic system may provide benefits, warranting further study.

Entities:  

Keywords:  lymphatic endothelial function; nitric oxide; nitric oxide-cGMP signaling

Mesh:

Substances:

Year:  2014        PMID: 24531811      PMCID: PMC4116402          DOI: 10.1152/ajpheart.00841.2013

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  55 in total

1.  Altered endothelial function in lambs with pulmonary hypertension and acute lung injury.

Authors:  J R Fineman; J Wong; T Mikhailov; P A Vanderford; H E Jerome; S J Soifer
Journal:  Pediatr Pulmonol       Date:  1999-03

Review 2.  Molecular regulation of microlymphatic formation and function: role of nitric oxide.

Authors:  Jeroen Hagendoorn; Timothy P Padera; Dai Fukumura; Rakesh K Jain
Journal:  Trends Cardiovasc Med       Date:  2005-07       Impact factor: 6.677

3.  Contraction-initiated NO-dependent lymphatic relaxation: a self-regulatory mechanism in rat thoracic duct.

Authors:  Olga Yu Gasheva; David C Zawieja; Anatoliy A Gashev
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

4.  Altered endothelium-dependent responses in lambs with pulmonary hypertension and increased pulmonary blood flow.

Authors:  V M Reddy; J Wong; J R Liddicoat; M Johengen; R Chang; J R Fineman
Journal:  Am J Physiol       Date:  1996-08

5.  Increased oxidative stress in lambs with increased pulmonary blood flow and pulmonary hypertension: role of NADPH oxidase and endothelial NO synthase.

Authors:  Albert C Grobe; Sandra M Wells; Eileen Benavidez; Peter Oishi; Anthony Azakie; Jeffrey R Fineman; Stephen M Black
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-06       Impact factor: 5.464

6.  Nitric oxide-endothelin-1 interactions after surgically induced acute increases in pulmonary blood flow in intact lambs.

Authors:  Peter Oishi; Anthony Azakie; Cynthia Harmon; Robert K Fitzgerald; Albert Grobe; Jie Xu; Karen Hendricks-Munoz; Stephen M Black; Jeffrey R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-12-09       Impact factor: 4.733

7.  Tezosentan, a combined parenteral endothelin receptor antagonist, produces pulmonary vasodilation in lambs with acute and chronic pulmonary hypertension.

Authors:  Robert K Fitzgerald; Peter Oishi; Boaz Ovadia; Gregory A Ross; Olaf Reinhartz; Michael J Johengen; Jeffrey R Fineman
Journal:  Pediatr Crit Care Med       Date:  2004-11       Impact factor: 3.624

8.  Association between fetal lymphedema and congenital cardiovascular defects in Turner syndrome.

Authors:  Melissa L Loscalzo; Phillip L Van; Vincent B Ho; Vladimir K Bakalov; Douglas R Rosing; Carol A Malone; Harry C Dietz; Carolyn A Bondy
Journal:  Pediatrics       Date:  2005-03       Impact factor: 7.124

9.  Endothelin-1 vasoactive responses in lambs with pulmonary hypertension and increased pulmonary blood flow.

Authors:  J Wong; V M Reddy; K Hendricks-Munoz; J R Liddicoat; R Gerrets; J R Fineman
Journal:  Am J Physiol       Date:  1995-12

10.  Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension.

Authors:  S M Black; J R Fineman; R H Steinhorn; J Bristow; S J Soifer
Journal:  Am J Physiol       Date:  1998-11
View more
  7 in total

1.  Lymphatic remodelling in response to lymphatic injury in the hind limbs of sheep.

Authors:  Tyler S Nelson; Zhanna Nepiyushchikh; Joshua S T Hooks; Mohammad S Razavi; Tristan Lewis; Cristina C Clement; Merrilee Thoresen; Matthew T Cribb; Mindy K Ross; Rudolph L Gleason; Laura Santambrogio; John F Peroni; J Brandon Dixon
Journal:  Nat Biomed Eng       Date:  2019-12-23       Impact factor: 25.671

Review 2.  Lymphatic dysfunction in critical illness.

Authors:  Edmund Burke; Sanjeev A Datar
Journal:  Curr Opin Pediatr       Date:  2018-06       Impact factor: 2.856

Review 3.  Lymphatic Vessel Network Structure and Physiology.

Authors:  Jerome W Breslin; Ying Yang; Joshua P Scallan; Richard S Sweat; Shaquria P Adderley; Walter L Murfee
Journal:  Compr Physiol       Date:  2018-12-13       Impact factor: 9.090

4.  Disrupted NOS signaling in lymphatic endothelial cells exposed to chronically increased pulmonary lymph flow.

Authors:  Sanjeev A Datar; Wenhui Gong; Youping He; Michael Johengen; Rebecca J Kameny; Gary W Raff; Emin Maltepe; Peter E Oishi; Jeffrey R Fineman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-13       Impact factor: 4.733

5.  KLF2-mediated disruption of PPAR-γ signaling in lymphatic endothelial cells exposed to chronically increased pulmonary lymph flow.

Authors:  Catherine J Morris; Rebecca J Kameny; Jason Boehme; Wenhui Gong; Youping He; Terry Zhu; Emin Maltepe; Gary W Raff; Jeffrey R Fineman; Sanjeev A Datar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-04-06       Impact factor: 4.733

6.  Characterization of rat tail lymphatic contractility and biomechanics: incorporating nitric oxide-mediated vasoregulation.

Authors:  Mohammad S Razavi; J Brandon Dixon; Rudolph L Gleason
Journal:  J R Soc Interface       Date:  2020-09-30       Impact factor: 4.118

7.  HIF-1α promotes cellular growth in lymphatic endothelial cells exposed to chronically elevated pulmonary lymph flow.

Authors:  Jason T Boehme; Catherine J Morris; Samuel R Chiacchia; Wenhui Gong; Katherine Y Wu; Rebecca J Kameny; Gary W Raff; Jeffrey R Fineman; Emin Maltepe; Sanjeev A Datar
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.